Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingbo Zhou

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
RMD Open|May 28, 2024
Increased risk of adverse gestational outcomes in pregnant women with primary Sjögren's syndromeZhen Tan, Meilin Shao, Yingbo Zhou, et al.
Rheumatology (Oxford, England)|May 27, 2025
Risk of heart disease in neonates born to mothers with primary Sjögren's syndrome: a multicenter retrospective studyYingbo Zhou, Meilin Shao, Yinzhao Jin, et al.
Cellular & Molecular Immunology|October 14, 2025
IL-18 drives the Bhlhe40-mediated pathogenic Th17 cell response and exacerbates autoimmune disease progressionYuan Tang, Yue Zhao, Zixiang Chen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 28, 2025
MDSC-derived IFN-β promotes T follicular helper cell response and exacerbates lupus developmentKe Rui, Zixiang Chen, Jun Liu, et al.
Journal of Leukocyte Biology|July 3, 2023
Single-cell clonal tracing of glandular and circulating T cells identifies a population of CD9+ CD8+ T cells in primary Sjogren's syndromeLing Chang, Zihan Zheng, Fan Xiao, et al.
Cellular & Molecular Immunology|November 12, 2022
Aryl hydrocarbon receptor activation drives polymorphonuclear myeloid-derived suppressor cell response and efficiently attenuates experimental Sjögren's syndromeYanxia Wei, Na Peng, Chong Deng, et al.
Iscience|October 9, 2023
Single-cell transcriptome profiling reveals immune and stromal cell heterogeneity in primary Sjögren's syndromeNan Xiang, Hao Xu, Zhou Zhou, et al.
Acta Pharmaceutica Sinica. B|April 27, 2026
Generative active learning guided discovery of a tobramycin and ciprofloxacin adjuvant against multidrug-resistant <i>Pseudomonas aeruginosa</i> infectionsSiyu Zhao, Jie Tang, Ziyang Du, et al.
Clinical Rheumatology|December 5, 2018
Correction to: the efficacy and safety of total glucosides of peony in the treatment of primary Sjögren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trialXia Liu, Xiaomei Li, Xiangpei Li, et al.
Clinical Rheumatology|October 4, 2018
The efficacy and safety of total glucosides of peony in the treatment of primary Sjögren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trialXia Liu, Xiaomei Li, Xiangpei Li, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
RMD Open|May 28, 2024
Increased risk of adverse gestational outcomes in pregnant women with primary Sjögren's syndromeZhen Tan, Meilin Shao, Yingbo Zhou, et al.
Rheumatology (Oxford, England)|May 27, 2025
Risk of heart disease in neonates born to mothers with primary Sjögren's syndrome: a multicenter retrospective studyYingbo Zhou, Meilin Shao, Yinzhao Jin, et al.
Cellular & Molecular Immunology|October 14, 2025
IL-18 drives the Bhlhe40-mediated pathogenic Th17 cell response and exacerbates autoimmune disease progressionYuan Tang, Yue Zhao, Zixiang Chen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 28, 2025
MDSC-derived IFN-β promotes T follicular helper cell response and exacerbates lupus developmentKe Rui, Zixiang Chen, Jun Liu, et al.
Journal of Leukocyte Biology|July 3, 2023
Single-cell clonal tracing of glandular and circulating T cells identifies a population of CD9+ CD8+ T cells in primary Sjogren's syndromeLing Chang, Zihan Zheng, Fan Xiao, et al.
Cellular & Molecular Immunology|November 12, 2022
Aryl hydrocarbon receptor activation drives polymorphonuclear myeloid-derived suppressor cell response and efficiently attenuates experimental Sjögren's syndromeYanxia Wei, Na Peng, Chong Deng, et al.
Iscience|October 9, 2023
Single-cell transcriptome profiling reveals immune and stromal cell heterogeneity in primary Sjögren's syndromeNan Xiang, Hao Xu, Zhou Zhou, et al.
Acta Pharmaceutica Sinica. B|April 27, 2026
Generative active learning guided discovery of a tobramycin and ciprofloxacin adjuvant against multidrug-resistant <i>Pseudomonas aeruginosa</i> infectionsSiyu Zhao, Jie Tang, Ziyang Du, et al.
Clinical Rheumatology|December 5, 2018
Correction to: the efficacy and safety of total glucosides of peony in the treatment of primary Sjögren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trialXia Liu, Xiaomei Li, Xiangpei Li, et al.
Clinical Rheumatology|October 4, 2018
The efficacy and safety of total glucosides of peony in the treatment of primary Sjögren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trialXia Liu, Xiaomei Li, Xiangpei Li, et al.
Pageof 3